| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 134, 596-602, Copyright © 1994 by Endocrine Society
ARTICLES |
GV Shah, W Rayford, MJ Noble, M Austenfeld, J Weigel, S Vamos and WK Mebust
Department of Urologic Surgery, University of Kansas Medical Center, Kansas City 66103.
Our recent study has shown that a calcitonin (CT)-like immunoreactive substance(s) is secreted by cultured prostate cells, and secretion of this material is significantly higher in malignant than in benign prostate cells. To test the hypothesis that prostatic CT may serve as a paracrine/neuroendocrine factor, the present study investigated for the presence of CT receptors in the prostate gland. Signal transduction mechanisms activated by CT were examined, and the study also tested its effects on prostate cell proliferation, as assessed by [3H]thymidine incorporation. The results show that high affinity binding sites for [125I]salmon CT were present in plasma membrane fractions of human prostate tissue specimens and the prostate cancer LnCaP cell line. The maximal binding for CT receptors was 564 +/- 163 fmol/mg protein, and the apparent dissociation constant (Kd) was 2.89 +/- 0.58 nM. CT induced a dose-dependent increase in cAMP generation in LnCaP cells. The effect of CT on cytoplasmic Ca2+ transients of LnCaP cells was examined by videofluoromicroscopy. CT (100 nM) induced a rapid and sharp increase in cytoplasmic Ca2+ concentrations in LnCaP cells. The CT-induced increase in cytoplasmic Ca2+ transients appeared to be biphasic (spike and plateau), and this increase was 4- to 10-fold during the initial phase. The profile of this response is characteristic of the activated Ca2+/phospholipid second messenger system. CT also caused a dose-dependent increase in [3H]thymidine incorporation by LnCaP cells. These results suggest that a locally secreted CT-like peptide(s) induces mitogenic responses in prostate cancer cells. This action seems to be mediated through activation of signaling mechanisms, leading to the accumulation of two different second messengers, cAMP and calcium. Activation of dual second messenger systems by CT receptors suggests that the peptide hormone may play an important role in rapidly growing cell populations during the process of tumor formation.
This article has been cited by other articles:
![]() |
M. Nakamura, B. Han, T. Nishishita, Y. Bai, and K. Kakudo Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers J. Mol. Endocrinol., December 1, 2007; 39(6): 375 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, D. W. Wolff, M.-F. Lin, and Y. Tu Vasoactive Intestinal Peptide Transactivates the Androgen Receptor through a Protein Kinase A-Dependent Extracellular Signal-Regulated Kinase Pathway in Prostate Cancer LNCaP Cells Mol. Pharmacol., July 1, 2007; 72(1): 73 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thomas, S. Chigurupati, M. Anbalagan, and G. Shah Calcitonin Increases Tumorigenicity of Prostate Cancer Cells: Evidence for the Role of Protein Kinase A and Urokinase-Type Plasminogen Receptor Mol. Endocrinol., August 1, 2006; 20(8): 1894 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, M. K. Bagchi, and I. C. Bagchi Identification of a Signaling Pathway Involving Progesterone Receptor, Calcitonin, and Tissue Tranglutaminase in Ishikawa Endometrial Cells Endocrinology, May 1, 2006; 147(5): 2147 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chigurupati, T. Kulkarni, S. Thomas, and G. Shah Calcitonin Stimulates Multiple Stages of Angiogenesis by Directly Acting on Endothelial Cells Cancer Res., September 15, 2005; 65(18): 8519 - 8529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bloomston, A. Durkin, I. Yang, M. Rojiani, A. S. Rosemurgy, S. Enkmann, T. J. Yeatman, and E. E. Zervos Identification of Molecular Markers Specific for Pancreatic Neuroendocrine Tumors by Genetic Profiling of Core Biopsies Ann. Surg. Oncol., April 1, 2004; 11(4): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Farini, A. Puglianiello, C. Mammi, G. Siracusa, and C. Moretti Dual Effect of Pituitary Adenylate Cyclase Activating Polypeptide on Prostate Tumor LNCaP Cells: Short- and Long-Term Exposure Affect Proliferation and Neuroendocrine Differentiation Endocrinology, April 1, 2003; 144(4): 1631 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Villa, C. Dal Fiume, A. Maestroni, A. Rubinacci, F. Ravasi, and F. Guidobono Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E627 - E633. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Segawa, M. Nakamura, Y. Nakamura, I. Mori, Y. Katsuoka, and K. Kakudo Phosphorylation of Mitogen-activated Protein Kinase is Inhibited by Calcitonin in DU145 Prostate Cancer Cells Cancer Res., August 1, 2001; 61(16): 6060 - 6063. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rocchi, F. Boudouresque, A. J. Zamora, X. Muracciole, E. Lechevallier, P.-M. Martin, and L'H. Ouafik Expression of Adrenomedullin and Peptide Amidation Activity in Human Prostate Cancer and in Human Prostate Cancer Cell Lines Cancer Res., February 1, 2001; 61(3): 1196 - 1206. [Abstract] [Full Text] |
||||
![]() |
F. Van Coppenolle, C. Slomianny, F. Carpentier, X. Le Bourhis, A. Ahidouch, D. Croix, G. Legrand, E. Dewailly, S. Fournier, H. Cousse, et al. Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E120 - E129. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Tverberg, M. F. Gustafson, T. L. Scott, I. V. Arzumanova, E. R. Provost, A. W. Yan, and S. A. Rawie Induction of Calcitonin and Calcitonin Receptor Expression in Rat Mammary Tissue during Pregnancy Endocrinology, October 1, 2000; 141(10): 3696 - 3702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Cox, P. D. Deeble, E. A. Bissonette, and S. J. Parsons Activated 3',5'-Cyclic AMP-dependent Protein Kinase Is Sufficient to Induce Neuroendocrine-like Differentiation of the LNCaP Prostate Tumor Cell Line J. Biol. Chem., April 28, 2000; 275(18): 13812 - 13818. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Evdokiou, L.-J. Raggatt, G. J. Atkins, and D. M. Findlay Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells Is Accompanied by Induction of p21WAF1/CIP1 and G2/M Arrest Mol. Endocrinol., October 1, 1999; 13(10): 1738 - 1750. [Abstract] [Full Text] |
||||
![]() |
M. E. Cox, P. D. Deeble, S. Lakhani, and S. J. Parsons Acquisition of Neuroendocrine Characteristics by Prostate Tumor Cells Is Reversible: Implications for Prostate Cancer Progression Cancer Res., August 1, 1999; 59(15): 3821 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Arbogast, G. V. Shah, and J. L. Voogt 3',5' Cyclic Adenosine Monophosphate Mediates the Salmon Calcitonin-Induced Increase in Hypothalamic Tyrosine Hydroxylase Activity Endocrinology, July 1, 1999; 140(7): 3273 - 3281. [Abstract] [Full Text] |
||||
![]() |
J.-C. Marie, A. Wakkach, A.-M. Coudray, E. Chastre, S. Berrih-Aknin, and C. Gespach Functional Expression of Receptors for Calcitonin Gene-Related Peptide, Calcitonin, and Vasoactive Intestinal Peptide in the Human Thymus and Thymomas from Myasthenia Gravis Patients J. Immunol., February 15, 1999; 162(4): 2103 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chen, R. W. Cho, P. J. S. Stork, and M. J. Weber Elevation of Cyclic Adenosine 3',5'-Monophosphate Potentiates Activation of Mitogen-activated Protein Kinase by Growth Factors in LNCaP Prostate Cancer Cells Cancer Res., January 1, 1999; 59(1): 213 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Putz, Z. Culig, I. E. Eder, C. Nessler-Menardi, G. Bartsch, H. Grunicke, F. Uberall, and H. Klocker Epidermal Growth Factor (EGF) Receptor Blockade Inhibits the Action of EGF, Insulin-like Growth Factor I, and a Protein Kinase A Activator on the Mitogen-activated Protein Kinase Pathway in Prostate Cancer Cell Lines Cancer Res., January 1, 1999; 59(1): 227 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Garabedian, P. A. Humphrey, and J. I. Gordon A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells PNAS, December 22, 1998; 95(26): 15382 - 15387. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, J.-F. Shyu, A. Santhanagopal, D. Inoue, J.-P. David, S. J. Dixon, W. C. Horne, and R. Baron The Calcitonin Receptor Stimulates Shc Tyrosine Phosphorylation and Erk1/2 Activation. INVOLVEMENT OF Gi, PROTEIN KINASE C, AND CALCIUM J. Biol. Chem., July 31, 1998; 273(31): 19809 - 19816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Rebhun, A. F. Castro, and L. A. Quilliam Identification of Guanine Nucleotide Exchange Factors (GEFs) for the Rap1 GTPase. REGULATION OF MR-GEF BY M-Ras-GTP INTERACTION J. Biol. Chem., November 3, 2000; 275(45): 34901 - 34908. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |